Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men

Journal of Lipid Research

Volumn 45, Issue 3, 2004, Pages 507-512

  Pihlajamäki, Jussi ^a   Gylling, Helena ^a   Miettinen, Tatu A ^b   Laakso, Markku ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Campesterol; Cholestanol; Cholestenol; Demosterol; Hyperinsulinemic euglycemic clamp; Insulin sensitivity; Lathosterol; Sitosterol; Squalene

Indexed keywords

BIOCHEMICAL MARKER; CAMPESTEROL; CHOLESTANOL; CHOLESTENOL; CHOLESTEROL; CHOLESTEROL DERIVATIVE; DESMOSTEROL; GLUCOSE; INSULIN; LATHOSTEROL; SITOSTEROL; SQUALENE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL ABSORPTION; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; HYPERINSULINEMIC EUGLYCEMIC CLAMP TECHNIQUE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; PRIORITY JOURNAL; WHOLE BODY GLUCOSE UPTAKE;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL; FASTING; HUMANS; INSULIN; INSULIN RESISTANCE; INTESTINAL ABSORPTION; MALE; MIDDLE AGED;

EID: 1542723726     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M300368-JLR200     Document Type: Article

References (26)

1. Reaven, G. M. 1991. Insulin resistance and compensatory hyperinsulinemia: role in hypertension, dyslipidemia, and coronary heart disease. Am. Heart J. 121: 1283-1288.
2. Taskinen, M. R. 2002. Diabetic dyslipidemia. Atheroscler. Suppl. 3: 47-51.
3. Miettinen, T. A., and H. Gylling. 2000. Cholesterol absorption efficiency and sterol metabolism in obesity. Atherosclerosis. 153: 241-248.
4. Chan, D. C., G. F. Watts, P. H. Barrett, F. H. O'Neill, and G. R. Thompson. 2003. Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndrome. Obes. Res. 11: 591-596.
5. Simonen, P. P., H. K. Gylling, and T. A. Miettinen. 2002. Diabetes contributes to cholesterol metabolism regardless of obesity. Diabetes Care. 25: 1511-1515.
6. Stranberg, T. E., V. Salomaa, H. Vanhanen, and T. A. Miettinen. 1996. Associations of fasting blood glucose with cholesterol absorption and synthesis in nondiabetic middle-aged men. Diabetes. 45:755-761.
7. Miettinen, T. A., R. S. Tilvis, and Y. A. Kesaniemi. 1990. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am. J. Epidemiol. 131: 20-31.
8. Diabetes Mellitus: Report of a WHO Study Group. World Health Organization, Geneva, Switzerland. 1985.
9. DeFronzo, R., J. Tobin, and R. Andres. 1979. Glucose clamp technique: a method for quantifying insulin secretion and insulin resistance. Am. J. Physiol. 237: E214-E223.
10. Haffner, S., P. Karhapāä, L. Mykkänen, and M. Laakso. 1994. Insulin resistance, body fat distribution, and sex hormones in men. Diabetes. 43: 212-219.
11. Bergman, R., D. Finegood, and M. Ader. 1985. Assessment of insulin sensitivity in vivo. Endocr. Rev. 5: 45-86.
12. Laakso, M., M. Uusitupa, J. Takala, H. Majander, T. Reijonen, and I. Penttilä. 1988. Effects of hypocaloric diet and insulin therapy on metabolic control and mechanisms of hyperglycemia in obese non-insulin-dependent diabetic subjects. Metabolism. 37: 1092-1100.
13. Ferrannini, E. 1988. The theoretical bases of indirect calorimetry: a review. Metabolism. 37: 287-301,
14. Laakso, M., H. Sarlund, and L. Mykkänen. 1990. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis. 10: 223-231.
15. Hawk, P., B. Oser, and W. Summerson. 1947. Practical Physiological Chemistry. 12th edition. Blakiston, Toronto, Canada. 814-822.
16. Gylling, H., and T. A. Miettinen. 2002. Inheritance of cholesterol metabolism of probands with high or low cholesterol absorption. J. Lipid Res. 43: 1472-1476.
17. Miettinen, T. A., and P. Koisisto. 1983. Non-cholesterol sterols and bile acid production in hypercholesterolaemic patients with ileal bypass. In Bile Acids and Cholesterol in Health and Disease. G. A. Paumgartner, A. W. Stiehl, and W. Gerok, editors. MTP Press, Lancaster, PA. 183-187.
18. Meigs, J. B. 2000. Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am. J. Epidemiol. 152: 908-911.
19. Simonen, P. P., H. Gylling, and T. A. Miettinen. 2002. Body weight modulates cholesterol metabolism in non-insulin dependent type 2 diabetics. Obes. Res. 10: 328-335.
20. Adeli, K., C. Taghibiglou, S. C. Van Iderstine, and G. F. Lewis. 2001. Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance. Trends Cardiovasc. Med. 11: 170-176.
21. Tobin, K. A., S. M. Ulven, G. U. Schuster, H. H. Steineger, S. M. Andresen, J. A. Gustafsson, and H. I. Nebb. 2002. Liver X receptors as insulin-mediating factors in fatty acid and cholesterol biosynthesis. J. Biol. Chem. 277: 10691-10697.
22. Horton, J. D., J. L. Goldstein, and M. S. Brown. 2002. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109: 1125-1131.
23. Yu, L., J. York, K. von Bergmann, D. Lutjohann, J. C. Cohen, and H. H. Hobbs. 2003. Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8. J. Biol. Chem. 278: 15565-15570.
24. Paolisso, G., M. Barbagallo, G. Petrella, E. Ragno, M. Barbieri, M. Giordano, and M. Varricchio. 2000. Effects of simvastatin and atorvastatin administration on insulin resistance and respiratory quotient in aged dyslipidemic non-insulin dependent diabetic patients. Atherosclerosis. 150: 1121-127.
25. Paniagua, J. A., J. Lopez-Miranda, A. Escribano, F. J. Berral, C. Marin, D. Bravo, E. Paz-Rojas, P. Gomez, M. Barcos, J. A. Moreno, and F. Perez-Jimenez. 2002. Cerivastatin improves insulin sensitivity and insulin secretion in early-state obese type 2 diabetes. Diabetes. 51: 2596-2603.
26. Mangaloglu, L., R. C. Cheung, S. C. Van Iderstine, C. Taghibiglou, L. Pontrelli, and K. Adeli. 2002. Treatment with atorvastatin ameliorates hepatic very-low-density lipoprotein overproduction in an animal model of insulin resistance, the fructose-fed Syrian golden hamster: evidence that reduced hypertriglyceridemia is accompanied by improved hepatic insulin sensitivity. Metabolism. 51: 409-418.